Biosensors lens that can detect glucose and other bodily functions developed

Advancement in the medical has come up with loads of miniature device development. Development of smart devices has been a chief agenda of the researchers that are associated with the medical sector.

Researchers at Oregan State University are in action to integrate biosensors into contact lenses which can be further used for the monitoring, diagnostic of glucose, and for the identification of pharmacokinetics scientific compounds.

The whole operation of the technology depends on the indium gallium zinc oxide– a newly created semiconductor that has already influence the consumer electronics sector. This semiconductor material was used to create a crystal clear film of field effect transistors that will have contains glucose oxidase– a type of enzyme that responds with the glucose.

As the pH of the surrounding around the field-effect transistors changes, the measure of current coursing through them also experiences changes. Since glucose oxidase separating glucose influences pH levels, the present yield of the transistors is distinctive of the concentration of encompassing glucose. So far the innovation is yet to be attempted on people, yet the film can recognize glucose at lesser concentration than that found in tears, which is a promising sign.

In spite, of the fact that noninvasive glucometry is a sacred vessel of the drug, this innovation can also be helpful in following different biomarkers other than glucose. Moreover, however, the innovation’s applications appear to be most stimulating as a component of contact lenses, it can be also installed inside a wide range of instruments, body implants, and gadgets that cooperate with the body.

The accomplishment of the project will be submitted at 253rd National Meeting & Exposition of the American Chemical Society (ACS). ACS is the largest scientific society around the global. The meeting is scheduled today to host the 14,000 presentations that are focused on science topics.

“These biosensors probably won’t put blood labs out of business,” says Gregory S. Herman, Ph.D. “But I think that we can do a lot of diagnostics using information that can be extracted from tear drops in the eye.”

This sensor won’t kick out the blood laboratories totally, but it can efficiently diagnose the tear drops and generate a useful data to identify the health concerns.

Ankit Kadam is a content writer working at Medical Device News. He is in the professional writing business since 1 year. He has hands on experience in writing product description, technological reviews, and marketing materials. He earns to travel and lives to explore. He can be reached at